跨导管肺门的未满足临床需求
Nnaoma Agwu1, Michael R Recto2, Arash Kheradvar3
1Department of Biomedical Engineering, University of California, 2420 Engineering Hall, Irvine, CA, 92697-2730, USA.
Annals of biomedical engineering
|August 5, 2023
概括
透气管肺置换 (TPVR) 为右心室外流通道阻塞提供了解决方案. 这项研究解决了儿科患者,特别是20公斤以下患者的未满足需求,探索了混合和周周直肠TPVR方法.
科学领域:
- 心脏病学 心脏病学
- 遗传性心脏病是一种先天性心脏病.
- 干预心脏病学 干预心脏病学
背景情况:
- 右心室外流管 (RVOT) 阻塞在先天性心脏病中很常见.
- 肺 insufficiency 往往需要肺置换 (PVR) 在生命的晚期.
- 透气管肺置换 (TPVR) 已经发展,但仍有未满足的需求.
研究的目的:
- 讨论儿童患者 (<20公斤) 进行肺置换的临床未满足需求.
- 扩大混合和其他TPVR方法的使用.
- 审查商业上可用的肺门的当前指示,禁忌和局限性.
主要方法:
- 对儿科TPVR未满足的临床需求的审查.
- 讨论混合和周周脉TPVR输送方法.
- 分析当前的肺置换指示和禁忌.
主要成果:
- 在20公斤以下的儿童中,TPVR存在显著的未满足需求.
- 混合和周周结膜方法对年轻患者来说是有前途的.
- 目前TPVR设备的临床局限性是一个关键问题.
结论:
- 对于小儿小病患者的TPVR需要进一步的创新.
- 混合和周周结合的策略可能会扩大TPVR的适用性.
- 解决设备的局限性对于成功的TPVR结果至关重要.
相关概念视频
Mitral Stenosis II: Clinical features and Diagnostic Tests
23
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
23
Mitral Stenosis III: Medical Management
13
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Mitral Stenosis IV: Nursing Management
14
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
14
Mitral Valve Prolapse II: Assessment and Management
22
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
22
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Mitral Stenosis I: Introduction
16
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
16


